Inspire Medical Systems
INSP
325 hedge funds and large institutions have $4.23B invested in Inspire Medical Systems in 2024 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 121 increasing their positions, 98 reducing their positions, and 70 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 98
1% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 70
1% less funds holding
Funds holding: 328 → 325 (-3)
2% less call options, than puts
Call options by funds: $68.8M | Put options by funds: $70.1M
1.08% less ownership
Funds ownership: 107.5% → 106.42% (-1.1%)
38% less capital invested
Capital invested by funds: $6.84B → $4.23B (-$2.6B)
89% less funds holding in top 10
Funds holding in top 10: 9 → 1 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$98.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$94.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$87.4M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$62.3M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$53.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$265M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$135M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$116M |
| 4 |
Jennison Associates
New York
|
-$47.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.9M |
INSP Hedge Fund Activity: Q2 2024 in Review
325 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2024, worth a combined $4.23B — down 38% from $6.84B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new INSP positions and 70 closed out — a net gain of 1 holder — while 121 added to existing stakes and 98 trimmed.
The largest buyer was UBS AM, adding an estimated $98.3M. The largest seller was Fidelity Investments, cutting an estimated $265M.
- 325 institutional investors held Inspire Medical Systems (INSP) as of Q2 2024, down from 328 in Q1 2024.
- Funds reported $4.23B of Inspire Medical Systems stock for Q2 2024, down 38% quarter-over-quarter.
- 71 funds opened new Inspire Medical Systems positions in Q2 2024 and 70 closed out, a net change of +1 holder.
- The largest Inspire Medical Systems buyer in Q2 2024 was UBS AM, an estimated $98.3M added.
- The largest Inspire Medical Systems seller in Q2 2024 was Fidelity Investments, an estimated $265M sold.
Based on aggregated 13F filings for Q2 2024.